Estrogen-receptor negative breast cancer
MONDO:0006513A subtype of breast cancer that is estrogen-receptor negative
Also known as: ER- breast cancer
3430 clinical trials for this condition and its sub-types, 24 tagged with Estrogen-receptor negative breast cancer itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Estrogen-receptor negative breast cancer
-
Triple-negative breast carcinoma 701 trials · 703 incl. sub-types
1 sub-type
- Basal-like breast carcinoma 5 trials
-
Cancer drug trial halted midway: what happened?
Disease control Stopped earlyThis study tested an experimental drug called VLS-101 in 102 people with advanced solid tumors, including breast, lung, ovarian, stomach, and pancreatic cancers that had stopped responding to standard treatments. The goal was to see if the drug could shrink tumors. However, the t…
Phase 2 • Sponsor: VelosBio Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New pill targets Hard-to-Treat cancers in early human test
Disease control Stopped earlyThis early-phase trial tested an experimental oral drug called NKT3447 in 23 adults with advanced or metastatic solid tumors that had stopped responding to standard treatments. The goal was to check safety, find the right dose, and see if the drug could shrink tumors. The study w…
Phase 1 • Sponsor: NiKang Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC